EBR Systems, Inc. (EBRCZ) Research

EBR Systems, Inc. focuses on developing internal medical devices that utilize wireless technology for tissue stimulation. A key offering is their WiSE cardiac resynchronization therapy (CRT) system, which leverages proprietary cable-free technology to deliver electrical pacing directly into the heart's left ventricle. This innovative approach aims to address and eliminate the typical difficulties associated with traditional wired leads, such as challenging insertion, unintended nerve activation, device displacement, complex removal procedures, and the need for frequent repositioning. The company was established in 2003 and operates from its headquarters in Sunnyvale, California.

Market snapshot

Symbol
EBRCZ
Price
$0.28
Day change
+48.56%
Market cap
$120.0M
P/E ratio
-21.68x
52-week range
0.1871-1.5
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 2 months

Peer companies

  • Adcock Ingram Holdings Limited (AIHLF)
  • Opthea Limited (CKDXF)
  • Claritas Pharmaceuticals, Inc. (CLAZF)
  • China Shineway Pharmaceutical Group Limited (CSWYF)
  • Inventiva S.A. (IVEVF)
  • Kindstar Globalgene Technology, Inc. (KDGTF)
  • Kossan Rubber Industries Bhd (KSRBF)
  • SS Innovations International, Inc. (SSII)

Open EBR Systems, Inc. (EBRCZ) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.